Issue link: https://viewer.e-digitaledition.com/i/1429214
" As physicians, we recognize that we see patients who are arriving with an unknown diagnosis. The process of diagnosing their condition and providing prognosis and options can be very daunting for them. Having empathy and compassion for what people are going through is really important." — SUNDEEP MANGLA, MD, INTERVENTIONAL NEURORADIOLOGIST, NSPC BRAIN & SPINE SURGERY collaborate and improve the lives of many people affected with this condition. "Patients who are not being treated need to be followed closely to avoid any effects the brain aneurysm may have on their lives, such as ongoing seizures," Dr. Pile- Spellman says. "Or an issue may come up regarding medication, or follow-up imaging may be needed." B y ke epi n g t r a c k of u n r up t u r e d brain aneurysm patients after they're discha rged to their home prov iders, NSPC physicians can also quickly locate those patients and inform them as new technologies or medications emerge that might benefit their case. TREATMENTS FOR MOYAMOYA DISEASE Moyamoya disease — a chronic condition that involves the gradual blockage of the major arteries of the brain — may present through aphasia, cognitive impairment, and movement and vision problems, as well as through TIAs and seizures. W h i le t h e p a t i e nt 's n e u r olo g i s t may ma na ge a patient 's Moya moya- a ssociated complications medica lly, revascularization surgery is required to either restore blood flow through the na rrowed vessels or to by pa ss them entirely. Another member of the NSPC team of neurointerventional specialists is John Grant, MD, FACS, a board-certified neurosurgeon who specializes in treating neurovascula r conditions, including Moyamoya disease. "Children do get Moyamoya disease," Dr. Grant says, "but the adult variety is generally felt to be an acquired lesion." A f ter ta king deta iled imag ing via cerebral angiogram, CT angiogram or single photon emission CT, Dr. Grant may use a direct extracranial-intracranial bypass procedure to revascularize the afflicted area. In this surgery, he performs a small craniotomy and then detaches an end of the superficial temporal artery from the scalp and reattaches it to the middle cerebral artery, thus diverting blood flow from the scalp to the affected portion of the brain. A l t e r n a t i v e l y , D r . G r a n t m a y reva scu la r ize t he a rea indirect ly by at t a ch i n g t he s uper f ici a l t empor a l a r ter y to t he su r face of t he bra i n or through placing of a graf t — a portion of the tempora lis muscle or a sma ll section of t he per it oneu m — on t he su r fa ce of the bra in to increa se blood f low to the a rea . UNCOMMON CARE FOR COMMON CONDITIONS Ne u r oi nt e r v e nt ion a l i s t s a t N S P C care for a full range of more common cerebrovascular conditions, including a r t er ia l st enosis, hemor rha g ic a nd i s c h e m i c s t r ok e , a n d s m a l l br a i n aneurysms. Even for routine conditions, Dr. Mangla has performed thousands of neurovascular interventions on Long Island and in both the Bronx and Brooklyn. Sundeep Mangla, MD DR. M A NGL A E A RNED his bachelor's degree and medical degree through an accelerated six-year program at Northeast Ohio Universities College of Medicine, where he also completed diagnostic radiology training. Dr. Mangla then completed a fellowship in diagnostic neuroradiology radiology at the University of Southern California and fellowships in interventional neuroradiology and endovascular neurosurgery at Yale University School of Medicine and University of Iowa Hospitals and Clinics. Board-certified in radiology with a certificate of added qualification in neuroradiology, Dr. Mangla specializes in interventional neuroradiology. He is specifically focused on furthering the diagnosis and treatment of complex cerebrovascular diseases. During his 20-year career, Dr. Mangla has performed thousands of neurovascular interventions in the region and has established stroke intervention programs in Long Island, Brooklyn and the Bronx. In addition to his extensive clinical work, Dr. Mangla has also led and participated in a robust spectrum of clinical trials and research. He has also been instrumental in the development and testing of novel biomedical diagnostics and therapeutics for the treatment of cerebrovascular disease. M D N E W S . C O M /// M D N E W S L O N G I S L A N D ■ 2 0 21 0 9